Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 3, 1997, Pages 1383-1388

  Ohdo, Shigehiro ^a   Makinosumi, Tomoko ^a   Ishizaki, Takashi ^a   Yukawa, Eiji ^a   Higuchi, Shun ^a   Nakano, Shigeyuki ^b   Ogawa, Nobuya ^c  

^a KYUSHU UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IRINOTECAN;

ANIMAL EXPERIMENT; ARTICLE; BODY WATER; CELL CYCLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DNA SYNTHESIS; LEUKOPENIA; LIGHT DARK CYCLE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE MARROW CELLS; CAMPTOTHECIN; CELL CYCLE; CIRCADIAN RHYTHM; LEUKOCYTE COUNT; MALE; MICE; MICE, INBRED ICR; TIME FACTORS; WEIGHT LOSS;

EID: 0031471160     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. ABELSON, H. T. AND PENMAN, S.: Induction of alkali labile links in cellular DNA by camptothecin. Biochem. Biophys. Res. Commun. 50: 1048-1054, 1973.
2. ARAKI, E., ISHIKAWA, M., IIGO, M., KOIDE, T., ITABASHI, M. AND HOSHI, A.: Relationship between development of diarrhea and the concentration of SN-38, an active metabolite of CPT-11, in the intestine and the blood plasma of athymic mice following intraperitoneal administration of CPT-11. Jpn. J. Cancer Res. 84: 697-702, 1993.
3. BHATTACHARYA, R. D. AND VON MAYEESBACH, H.: Circadian variation of liver esterases. Eur. J. Appl. Physiol. 46: 85-89, 1981.
4. BJARNASON, G. A. AND HRUSHESKY, W. J. M.: Cancer chronotherapy. In Circadian Cancer Therapy, ed. by W. J. M. Hrushesky, pp. 241-263, CRC Press, Boca Raton, 1994.
5. BOUGHATTAS, N. A., LEVI, F., FOURNIER, C., LEMAIGRE, G., ROULON, A., HECQUET, B., MATHE, G. AND REINBERG, A.: Circadian rhythm in toxicities and tissue uptake of 1, 2-diamminocyclohexane (trans-1) oxalatoplatinum(II) in mice. Cancer Res. 49: 3362-3368, 1989.
6. CAL, J. C., DORIAN, C. AND CAMBAR, J.: Circadian and circannual changes in nephrotoxic effects of heavy metals and antibiotics. Annu. Rev. Chronopharmacol. 2: 143-176, 1986.
7. COVEY, J. M., JAXEL, C., KOHN, K. W. AND POMMIER, Y.: Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. Cancer Res. 49: 5016-5022, 1989.
8. DREWINKO, B., FREIREICH, E. J. AND GOTTLIEB, J. A.: Lethal activity of camptothecin sodium on human lymphoma cells. Cancer Res. 34: 747-750, 1974.
9. ENGLISH, J., AHERNE, G. W. AND MARKS, V.: The effect of timing of a single injection on the toxicity of methotrexate in the rat. Cancer Chemother. Pharmacol. 9: 114-117, 1982.
10. HALBERG, F. AND HALBERG, E.: Chronopharmacology and further steps toward chronotherapy. In Pharmacokinetic Basis for Drug Treatment, ed. by L. Z. Benet, N. Massoud and J. G. Gambertoglio, pp.221-248, Raven Press, New York, 1984.
11. HERTZBERG, R. P., CARANFA, M. J. AND HECHT, S. M.: On the mechanism of topoisomerase I inhibition by camptothecin: Evidence for binding to an enzyme-DNA complex. Biochemistry 28: 4629-4638, 1989.
12. HOLM, C., COVEY, J. M., KERRIGAN, D. AND POMMIER, Y.: Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res. 49: 6365-6368, 1989.
13. HORWITZ, M. S. AND HORWITZ, S. B.: Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecin. Biochem. Biophys. Res. Commun. 45: 723-727, 1971.
14. HORWITZ, S. B., CHANG, C. K. AND GROLLMAN, A. P.: Studies on camptothecin: I. Effects on nucleic acid and protein synthesis. Mol. Pharmacol. 7: 632-644, 1971.
15. HSIANG, Y. H., HERTZBERG, R., HECHT, S. AND LIU, L. F.: Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260: 14873-14878, 1985.
16. HSIANG, Y. H., LIHOU, M. G. AND LIU, L. F.: Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptotecin. Cancer Res. 49: 5077-5082, 1989a.
17. HSIANG, Y. H. AND LIU, L. F.: Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res. 48: 1722-1726, 1988.
18. HSIANG, Y. H., LIU, L. F., WALL, M. E., WANI, M. C., NICHOLAS, A. W., MANIKUMAR, G., KIRSCHENBAUM, S., SILBER, R. AND POTMESIL, M.: DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogs. Cancer Res. 49: 4385-4389, 1989b.
19. JAXEL, C., KOHN, K. W., WANI, M. C., WALL, M. E. AND POMMIER, Y.: Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: Evidence for a specific receptor site and a relation to antitumor activity. Cancer Res. 49: 1465-1469, 1989.
20. KANEDA, N. AND YOKOKURA, T.: Nonlinear pharmacokinetics of CPT-11 in rats. Cancer Res. 50: 1721-1725, 1990.
21. KAWATO, Y., SEKIGUCHI, M., AKAHANE, K., TSUTOMI, Y., HIROTA, Y., KUGA, H., SUZUKI, W., HAKUSUI, H. AND SATO, K.: Inhibitory activity of camptothecin derivatives against acetylcholinesterase in dogs and their binding activity to acetylcholine receptors in rats. J. Pharm. Pharmacol. 45: 444-448, 1993.
22. KESSEL, D.: Some determinants of camptothecin responsiveness in leukemia L1210 cells. Cancer Res. 31: 1883-1887, 1971.
23. KESSEL, D., BOSMANN, H. B. AND LOHR, K.: Camptothecin effects on DNA synthesis in murine leukemia cells. Biochim. Biophys. Acta 269: 210-216, 1972.
24. KOJIMA, A., SHINKAI, T. AND SAIJO, N.: Cytogenetic effects of CPT-11 and its active metabolite, SN-38 on human lymphocytes. Jpn. J. Clin. Oncol. 23: 116-122, 1993.
25. LABAT, C., MANSOUR, K., MALMARY, M. F., TERRISSOL, M. AND OUSTRIN, J.: Chronotoxicity of methotrexate in mice after intraperitoneal administration. Chronobiologia 14: 267-275, 1987.
26. LABRECQUE, G., BELANGER, P. M., DORE, F. AND LALANDE, M.: 24-hour variations in the distribution of labeled microspheres to the intestine, liver and kidneys. Annu. Rev. Chronopharmacol. 5: 445-448, 1988.
27. LEVI, F., HORVATH, C., MECHKOURT, M., ROULON, A., BAILLEUL, F., LEMAIGRE, G., REINBERG, A. AND MATHE, G.: Circadian time dependence of murine tolerance for the alkylating agent peptichemio. Eur. J. Cancer Clin. Oncol. 23: 487-497, 1987.
28. LI, L. H., FRASER, T. J., OLIN, E. J. AND BHUYAN, B. K.: Action of camptothecin on mammalian cells in culture. Cancer Res. 32: 2643-2650, 1972.
29. LIU, L. F. AND MILLER, K. G.: Eukaryotic DNA topoisomerases: Two forms of type I DNA topoisomerases from HeLa cell nuclei. Proc. Natl. Acad. Sci. U.S.A. 78: 3487-3491, 1981.
30. MATTERN, M. R., MONG, S. M., BARTUS, H. F., MIRABELLI, C. K., CROOKE, S. T. AND JOHNSON, R. K.: Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. Cancer Res. 47: 1793-1798, 1987.
31. NEGORO, S., FUKUOKA, M., MASUDA, N., TAKADA, M., KUSUNOKI, Y., MATSUI, K., TAKIKUJI, N., KUDOH, S., NIITANI, H. AND TAGUCHI, T.: Phase I study of weekly intravenous infusions of CPT-11, a new derivative of camptothecin, in the treatment of advanced non-small-cell lung cancer. J. Natl. Cancer Inst. 83: 1164-1168, 1991.
32. OHDO, S., NAKANO, S. AND OGAWA, N.: Chronopharmacological study of sodium valproate in mice. Jpn. J. Pharmacol. 47: 11-19, 1988.
33. OHDO, S., OGAWA, N., NAKANO, S. AND HIGUCHI, S.: Influence of feeding schedule on the Chronopharmacological aspects of sodium valproate in mice. J. Pharmacol. Exp. Ther. 278: 74-81, 1996.
34. OHDO, S., OGAWA, N. AND SONG, J. G.: Chronopharmacological study of acetylsalicylic acid in mice. Eur. J. Pharmacol. 293: 151-157, 1995.
35. REINBERG, A. AND SMOLENSKY, M. H.: Orcadian changes of drug disposition in man. Clin. Pharmacokinet. 7: 401-420, 1982.
36. SLETVOLD, O. AND LAERUM, O. D.: Alterations of cell cycle distribution in the bone marrow of aging mice measured by flow cytometry. Exp. Gerontol. 23: 43-58, 1988.
37. SONG, J. G., NAKANO, S., OHDO, S. AND OGAWA, N.: Chronotoxicity and chronopharmacokinetics of methotrexate in mice: modification by feeding schedule. Jpn. J. Pharmacol. 62: 373-378, 1993.
38. SPATARO, A. AND KESSEL, D.: Studies on camptothecin-induced degradation and apparent reaggregation of DNA from L1210 cells. Biochem. Biophys. Res. Commun. 48: 643-648, 1972.
39. TAKAYANAGI, I., KOIKE, K., TAGAWA, M. AND MITSUHASHI, E.: Some pharmacological properties of a new antitumor drug, CPT-11, in isolated muscle preparations. Gen. Pharmacol. 20: 763-766, 1989.
40. TOBEY, R. A.: Effects of cytosine arabinoside, daunomycin, mithramycin, azacytidine, adriamycin, and camptothecin on mammalian cell cycle traverse. Cancer Res. 32: 2720-2725, 1972.
41. VACHON, C. AND SAVOIE, L.: Circadian variation of food intake and digestive tract contents in the rat. Physiol. Behav. 39: 629-632, 1987.